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Abstract
Using Fishbein’s multiattribute model as a theoretical background, this paper develops an
empirical model to assess and identify attributes of agrobiotechnology and individual
characteristics determining public acceptance of biotech foods.  This paper uses a database
collected in the United States and United Kingdom in November, 2000.
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A Multiattribute Model of Public 
Acceptance of Genetically Modified Organisms
Introduction
When biotechnology forms of major crops appeared in market in the mid-1990s,
agricultural biotechnology has been hailed as a major technological breakthrough that would
potentially revolutionize the way crops are produced while enhancing the nutritional value of
food products.  Since then, because of their ability to increase yields and reduce pest-
management cost, the adoption of bio-engineered seeds for corn, soybean and cotton has
dramatically expanded.  In line with the expansion in production, Hoban (1998) reported that
more than 70 percent of consumers surveyed in 1992, 1995, and 1997 supported the application
of biotechnology in food production.  Beginning from 1999, however, U.S. consumers started to
question the credibility of the FDA’s approval of transgenic crops and began to diverge with
scientists’ view that GMOs essentially pose no additional health risks as compared to nonGMOs
(Miranowski, 1999; Jostling et al., 1999; ERS, 2000b). 
Growing consumer concerns raised such intriguing issues as adoption of identity
preservation, market segregation, and labeling as ways of distinguishing GMOs from nonGMOs
throughout the food supply chain.  These issues of identity preservation, segregation, and
labeling constitute the most integral components of the current debate about transgenic crops and
the stakes are huge for all involved in the food supply chain including consumers, farmers, food
manufacturers, retailers, and government as well as agri-biotechnology firms.  Fundamental to
the concepts of identity preservation, market segregation, and labeling is public acceptability of
biotech foods.  How consumers perceive and assess potential risks and benefits associated with
agri-biotechnology will determine the emergence and magnitude of the demand for nonbiotech-2-
foods, thus the scope of market segregation and the type of labeling system.  Hence,
understanding the nature of consumer preferences about biotech foods is of profound significance
to the stakeholders including farmers, agribiotechnology  industry, and policy makers. 
The main objective of this research is to develop empirical models to identify factors
shaping public acceptance of biotech foods.  In particular, this paper evaluates how consumer
perceptions about various attributes of agrobiotechnology are related to public acceptance of
biotech foods.  Eight attributes including four negative and three positive aspects of
agrobiotechnolgy are considered in this paper.  Measuring the relative effect of risk and benefit
perceptions on public acceptance would present an important insight into understanding public
sentiment about biotech foods.  The influence of consumer knowledge about and awareness of
biotech issues, the level of trust on regulatory agency and global attitude toward food safety on
public acceptance of biotech foods are also estimated along with risk and benefit perceptions. 
Subsequently, given the dominant role of health risk in the debate about biotech foods,
this paper develops health risk perception models and identify individual characteristics
impacting health risk perception from eating foods containing biotech ingredients.  To develop
those models exploring public acceptance of biotech foods and health risk perception, this paper
uses a large-scale survey database collected in November, 2000 in two countries including the
United States and United Kingdom.  The database includes 3,060 respondents from the United
States and 2,568 respondents from the United Kingdom.  Hence, the database presents an
opportunity to compare the preferences of the U.S. and U.K. consumers in regard to foods
containing biotech ingredients.1 Each focus group consisted of eight people recruited locally.  The studies were
conducted in Carbondale, Illinois in the fall, 2000.
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Survey Design
Survey instrument was designed primarily to evaluate factors underlying public attitude
toward genetically modified organisms.  The instrument was tested and question wording was
refined in light of the results of three focus group studies.
1  The survey was implemented by mail
in November, 2000 and the data were collected using a consumer panel of about 400,000
consumers across the United States maintained by the National Panel Diary (NPD) group.  The
NPD group is a marketing consulting firm specializing in the areas of researching consumer
behavior and food marketing. 
Survey method using such an established panel is called ‘permission-based survey’ and
increasingly used in exploring various respects of consumer behavior for academic or
commercial purposes.  Advantages associated with the permission-based survey include: (1)
response rate is higher than other regular surveys, and (2)  demographic information is disclosed
for non-returners as well as returners, which would permit researchers to assess potential non-
response bias.  Questionnaires were distributed to 5,200 households selected across the United
States by random sampling: about 3,000 households returned completed questionnaires, yielding
a response rate of nearly 58 percent.
The sample is drawn stratified by geographic regions, market size, household head age,
education and income to balance with the U.S. census for adults.  Table 1 compares the sample
with the U.S. census based on socioeconomic and demographic profiles.  The comparison
suggests that the survey sample is remarkably well representative of the U.S. census in most of-4-
the demographic categories.  In addition, Table 1 shows that the sample is drawn from four
geographic regions (Northeast, Midwest/North Central, South, and West) quite in proportion
with the U.S. census.  The only noticeable discrepancy is the moderate under-representation of
‘Not Employed’ category in the sample as compared with the U.S. census.  
The same instrument was implemented to consumers in the United Kingdom.  The survey
in the U.K. used on-line method instead of mail.  The on-line method uses the Internet as a data
collection tool and provides the following advantages over the more traditional methods (e.g.,
mail, mall, phone): (1) faster response time, (2) lower costs versus mall or mail/phone; (3) ability
to follow up with panelists quickly and inexpensively, and (4) more current samples.  However, a
question arise regarding the validity of on-line method: if online samples are matched
demographically to actual census demographic characteristics, are the results obtained via the
online methodology the same as those obtained using the traditional data collection methods?  
In addition to the potential discrepancy of demographic characteristics, the on-line
method could result in a further bias due to the fact that the sampling was restricted to those who
have an access to computer and Internet.  A possible conjecture about the direction of the bias is
that consumers with an access to Internet would be more technologically-oriented and more
likely to accept new technologies than those without the access, leading to an upwardly biased
acceptance rate.  Accordingly, the results from the U.K. survey should be interpreted in light of
the potential biases that may be associated with this particular sampling method.  
About 9,000 consumers voluntarily registered to participate in the NPD on-line survey
panel in the U.K.  For this survey, the NPD group sent  all of 9,000 consumers e-mails providing
a brief description of the survey and leading them to the website  exhibiting the questionnaire. 2 A little fewer than 1,000 consumers responded at the first day of opening the survey
field on the Internet.
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Nearly 2,600 consumers returned completed surveys within the first seven days after they were
contacted by the NPD via e-mails.
2
Multi-attribute Model
Fishbein’s multiattribute model (attitude toward an object) offers a conceptual framework
for analyzing the linkage between overall attitude toward agrobiotechnology and perceptions
about various attributes associated with the application of biotechnology to crop and food
production (Fishbein, 1963; Fishbein & Ajzen, 1975).  Attitudes are an expression of inner
feelings that reflect whether a person is favorably predisposed to some object.  While measuring
attitudes helps understand consumer’s overall evaluation for an object, it fails to present specific
insights as to what influences or explains a consumer’s evaluative rating.  The multiattribute
model views an attitude object as possessing multiple characteristics (attributes) that establish the
basis of consumer’s attitude.   Fishbein’s model is written as,
(1) ATTITUDEt = !i=1 !it Zit         i = 1, 2,......n
where ! ! ! !it is the importance weight or the goodness or badness of attribute(i) evaluated by
consumer (t) and Zit is the strength of the belief of consumer (t) that the object has an attribute
(i); and n is the number of salient attributes.  The model thus proposes that attitude toward an
object is based on the summed set of beliefs about the object’s attributes weighted by the
evaluation of these attributes.  In marketing studies, both the evaluation (! ! ! !it) and belief (Zit) are
obtained through consumer surveys, and used for calculation of the overall attitude toward an
object.  -6-
The data used in this study provide cross-sectional information on overall attitude toward
agrobiotechnology and strength of the belief that agrobiotechnology has certain attributes. 
Consequently, by modifying equation (1) into a stochastic regression model, we can statistically
measure the importance weight or evaluation of the goodness or badness of attribute (i),
(2)   ATTITUDEt = ! !it Zit    + "t    i = 1, 2,......n    
where subscript (t) denotes consumers; Zt is a vector of perceived attributes of agrobiotechnology
and  ! ! ! ! now represents a vector of unknown regression coefficients to be estimated.  Magnitudes
and signs of the estimated coefficients would measure the importance  and goodness or badness
of each attribute, respectively, in overall attitude toward agrobiotechnology (Steenkamp, 1997).
Model Specification
The dependent variable in this study, public acceptance of agrobiotechnology, was
measured with six-point scale ranging from Strongly Oppose to Strongly Support.  About 32
percent of U.S. consumers expressed support for the use of biotechnology in crop production,
while 31 percent opposed it (Table 2).  Approximately 37 percent responded that they couldn’t
form their opinions.  The percentage of U.K. consumers in support of agrobiotechnology (38 %)
was a bit higher as compared to the U.S. consumers, while considerably higher percentage (46
%) opposed the use of biotechnology in crop production.  Yet the most noticeable difference lies
in the considerably lower percentage of respondents (16 %) who chose ‘Don’t Know’ category in
comparison with the U.S. consumers. 
In equation (1), consumers’ attitude toward agrobiotechnology is hypothesized to be
determined by a vector of perceived attributes of agrobiotechnology (Z).   Eight perceived
attributes in relation to agrobiotechnology are considered in this study: (1) health risks; (2)3 The index is created by adding up the two variables.  Hence, the index would range
theoretically from 2 to 12 with 12 representing absolute concerns about health and environments. 
Other indexes are similarly constructed. 
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environmental risks; (3) moral and ethical considerations; (4) the image of multinational
corporations as the primary beneficiaries of biotechnology; (5) the growing control of
multinational corporations over farming; (6) potential increase in yields; (7) reduced use of
chemical in crop production; and (8) potential improvement in nutritional composition.  The first
four attributes describe potential risks agrobiotechnolgoy poses while the latter three captures
potentially beneficial aspects of agrobiotechnology..  
There were considerable correlations (ranging from 0.54 to 0.76) among consumer
perceptions about the eight attributes of agrobiotechnology.  To cope with potential
multicollenearity problem in specifying the empirical model, the eight perceived attributes were
reduced to four variables: (i) an index of risk perception (RISK_1) using consumer perceptions
about health and environmental risks
3; (ii) consumer perception about moral and ethical aspects
of agrobiotechnology (MORAL_2); (iii) an index of consumer perceptions about multinational
corporations (MULTI_3) based on consumer perceptions about (4) and (5); and (iv) an index of
benefit perception (BENEFIT_4) based on consumer perceptions about (5), (6) and (7).  
In addition to the four indexes representing eight perceived attributes specific to
agrobiotechnology (Z1), the vector Z is augmented in this study to include global attitude toward
food safety (Z2), self-rated knowledge about agrobiotechnology (Z3), awareness of the
agrobiotechnology issues (Z4), and the level of trust on regulatory authority (Z5).  Accordingly,
the vector Z is partitioned into five subgroups Z = [Z1, Z2, Z3, Z4,  Z5].  Table 3 presents a general
description of the variables included in the empirical model along with summary statistics. -8-
Estimation Results
Public acceptance of agrobiotechnology in this study was measured with six-point scale
ranging from ‘Strongly Oppose’ to ‘Strongly Support’.  The ordinal property of the measurement
scale requires the application of a multi-ordered response model (Madala, 1983).  Ordered probit
model was adapted to estimate three models based on (1) pooled data, (2) U.S. data, and (3) U.K
data.  Table 3 presents estimated parameters and asymptotic t-values for the three models along
with other summary statistics.  The hypotheses that all coefficients in the ordered probit models
are simultaneously equal to zero was tested using Loglikelihood Ratio (LR) which is #
2
distributed.  The calculated LR ratio are 243, 198, and 211 for the pooled, U.S. and U.K. data,
respectively.  Critical value is 25.19 at a 0.01 probability level with 12 degrees of freedom, thus
failing to reject the hypotheses.  The test results suggest that the specified models have the
capabilities to explain the variation in the consumer attitudes across individuals.
Estimated results from the pooled data clearly indicate that not only risk but benefit
perceptions in relation to agrobiotechnology play an important role in shaping consumer attitudes
toward the use of biotechnology in crop production.  If consumers perceived risks on human
health from eating biotech foods or believed that agrobiotechnology posed hazards on ecosystem,
then they were more likely to oppose agrobiotechnology.  In contrast, consumers who associate
agrobiotechnology with various benefits as represented by the index, BENEFIT_4, were likely to
develop more favorable attitude toward the use of biotechnology in crop and food production
than those who do not.
In addition to risk and benefit perceptions, moral and ethical considerations (MORAL_2)
and perceptions about multinational corporations had a measurable impact on shaping consumer-9-
acceptance of agrobiotechnology.  If consumers perceive that it is ethically morally wrong to use
biotechnology, they tended to develop negative attitude toward agrobiotechnology.  Similarly,
consumers were likely to oppose agrobiotechnology if they believed that corporations were the
main beneficiaries from agrobiotechnology, while consumers assumed most of the risk or if they
perceived that the influence of multinational seed companies on farming was growing.  These
results suggest that consumer attitudes toward agrobiotechnology are shaped not only by risk and
benefit perceptions but also by other considerations such as moral values or beliefs about
multinational corporations.
Global attitude toward food safety (SAFE_1) was also found to exert a significant impact
on public acceptance of agrobiotechnology.  If consumers consider food safety an important
consideration in food purchasing decisions, they had more negative attitude toward
agrobiotechnology than those who do not.  Knowledge and awareness were important
determinants of public acceptance of agrobiotechnology.  Self-rated knowledge about and
awareness of biotech issues were positively associated with public acceptance of
agrobiotechnology, indicating that consumers who think they are knowledgeable about or well
aware of biotech issues are more likely to support the application of biotechnology in crop
production than those who do not.  The degree of trust consumers place on regulatory agency in
regard to biotech foods also significantly influenced public acceptance of agrobiotechnology.  If
consumers believe that FDA has adequate rules and regulations in regard to biotech foods, they
were more likely to support the use of biotechnology in crop production.  An intriguing result is
that U.S. consumers were less likely to support agrobiotechnology in relative to U.K. consumers
with other variables being held constant.  This may be due to the bias associated with the-10-
different sampling methods used in the U.S. and U.K.  
This paper split the data into the U.S. and U.K. and estimated the same model for each
country.  Comparison of the estimated results from the two countries display important
differences in terms of factors influencing consumer attitudes toward agrobiotechnology.  For
example, food safety consideration was an important component impacting consumer acceptance
of biotech foods in the U.K. whereas it was not in the U.S.  In addition, self-rated knowledge
about biotech issues was statistically significant and positively associated with public acceptance
in the U.S. but it did not play a significant role in the U.K.   
Perceived Health Risk
The multiattribute model has identified perception about health risk as an important
determinant of overall attitude toward agrobiotechnology.  In this section, we develop two
empirical models to assess demographic and other factors underlying consumer perception about
health risk from eating foods containing biotech ingredients.  The first model recognizes two
major components of perceived risk (i.g., probability and severity of adverse outcome) in
addition to demographic profiles, whereas the second model attempts to link consumer
awareness, trust on regulatory agency, labeling and availability of information about biotech
issues to health risk perception.    
Probability and Severity of Adverse Outcome
We define perceived health risk as a consumer’s subjective feeling about the probability
that a choice may bring an adverse outcome to his/her health (Olgethorpe and Monroe, 1994). 
This definition involves two aspects of health risk: (1) probability and (2) severity of adverse
outcome.  Given the definition, we model perceived health risk as a function of measures of the-11-
probability that adverse outcome would occur and severity of the adverse outcome.  The
probability measure was constructed using consumer responses to the question, What do you
think of the likelihood of health hazards from eating genetically modified foods? (Table 5).  Six-
point scale was used ranging from 1 = Extremely Low to 6 = Extremely High.  The severity
measure was constructed using another six-point scale (1= Not at all severe to 6 = Extremely
severe) to the question If any health problems should occur, how severe do you think they would
be?  This model is extended to incorporate demographic characteristics including age, education
and gender.
Estimation results for both US and UK show that the measures of both probability and
severity strongly influence consumer perception about health risks from eating biotech foods. 
The results suggest that communication or promotional efforts to deal with consumer perception
about the safety of biotech foods should address both the probability of an adverse health
outcome to occur and the severity of such an adverse outcome.  
For the U.S. consumers, perception of health risks differed significantly by gender and the
level of education but not by age.  Males were less likely to perceive health risks from biotech
foods than females.  The higher the level of education the less likely to perceive health risks from
biotech foods.  In contrast, U.K. consumers’ perception of health risks did not vary by the level
of education but was significantly influenced by age and gender.  Table 6 reports estimated
parameters and asymptotic t-values along with other summary statistics.  
Awareness, Trust, Information, and Labeling
The following model links consumer perception of health risks to various measures of
consume psychological variables including: (1) awareness of agrobiotechnology issues-12-
(AWARENESS), (2) public confidence on regulatory agency regarding the safety of biotech
foods (TRUST), (3) consumer perception of information availability (INFORMATION), and (4)
consumer reaction to the lack of labeling system to differentiate nonbiotech from biotech foods
(LABEL).  The four variables were found to play an important role in shaping consumer
perception about health risks from biotech foods.  Consumers with higher awareness of
agrobiotechnology issues were less likely to perceive health risks.  If consumers believe that
regulatory agency had adequate rules and regulations in regard to biotech foods, then they were
less likely to perceive health risks than those who do not.  Consumers who feel that there is
enough information about biotech foods were less likely to perceive health risks.  Finally, if
consumers feel outraged that conventional foods are currently not labeled differently than biotech
foods in the grocery stores, they were more likely to perceive health risks.  In other words, the
fact that consumers do not have the right to choose between nonbiotech and biotech foods
heightens health risk perception. 
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Census Region Household Head
Education
     Northeast 21.2 18.9 Grade  1.9 4.7
     Midwest 28.0 23.6 Some High 9.3 8.8
     South 34.1 35.8 Graduated High 36.8 35.6
    West 16.8 21.8 Some College 23.4 23.8
Graduated 18.9 18.2
Post College 9.6 9.2
Market Size Household Head
Occupation
 <1,000,000 31.0 28.0 White Collar 41.3 44.7
1,000,000 - 2,499,999 22.6 24.6 Blue Collar 31.9 30.4
2,500,000 22.5 28.4 Student 1.0 0.9
Non-MSA 23.8 19.0 Retired 20.5 23.5
Other 5.2 0.5
Household Head Age Household
Income
     18 - 24 years     3.7 6.4 <$15,000 14.9 14.7
     25 - 34 years 17.9 21.4 $15,000 - $24,999 11.6 12.2
     35 - 44 years 27.5 27.3 $25,000 - $34,999 13.6 13.1
     45 - 54 years 24.2 22.9 $35,000 - $49,999 18.2 16.9
     55 - 64 years 19.0 15.5 $50,000 - $74,999 21.3 20.5
     65 - 69 years 7.7 6.6 $75,000 + 20.4 22.7
Source: NPD Genetically Modified Organism (GMOs) Consumer Survey, 2000-15-
Table 2.  Public acceptance of agrobiotechnology: U.S. and U.K.
Support (%) Oppose (%) Don’t Know (%)
United States 32  31 37
United Kingdom 38 46 16
Note: Public acceptance of agrobiotechnology was measured with six-point scale ranging from ‘Strongly
Oppose’ to ‘Strongly Support.  ‘Support’ is the summation of the higher three categories and ‘Oppose’ is
for the lower three categories.
Source: NPD Genetically Modified Organisms Consumer Survey, 2000.-16-
Table 3.  Definitions and descriptive statistics of variables used in the Multi-attribute model
Variable Description Mean St. Dev.
Dependent Variable
   Public Acceptance Attitude about the use of biotech in crop production
X1 Subgroup
  RISK_1 
     Health Risks
     Environmental Risks
       
  MORAL_2
  MULTI_3
      Beneficiary
      Control on farming
  BENEFIT_4
      Increase in yields
      Chemical use
      Nutritional contents
Biotech foods pose health hazards 
Agrobiotechnology poses hazards on eco-system
It is morally and ethically wrong to use biotechnology
Multinational corporations are primary beneficiaries of
agrobiotechnology, while consumers assume most of
the risks
Multinational corporations are increasingly controlling
farming
Agrobiotechnology reduces world food shortages by
increasing yields
Agrobiotechnology reduces the use of chemical in crop
production










    SAFE_1
   
Importance of food safety in food purchasing decisions 4.89 (4.37) 1.13(1.43)
X3 Subgroup
   Knowledge How would you rate your knowledge about GMOs? 2.38 (3.15) 1.32 (1.32)
X4 Subgroup
    AWARE Have you ever read or heard about (terms)?
2 3.06 (3.97) 1.39(1.24)
X5 Subgroup
    TRUST I believe that FDA has adequate rules and regulations
in regard to GMOs
4.88 (5.24) 1.34(1.28)
11 = Never; 6 = All the time.  All other questions are measured with six-point scale ranging from 1 = Disagree
Completely to 6 = Agree Completely.   
 2 Awareness index is constructed by adding up ‘Yes’ responses to questions
including:(1)Genetical engineering, (2)Gene splicing, (3) Transgenic crops, (4) Roundup Ready soybean, (5) Bt
corn, (6) BST milk, (7) Starlink corn, (8) Monarch butterflies, (9) Liberty Link corn, (10) Frankenfood, (11) Gene
escape.
Note: Numbers within parentheses represent means and standard deviations for UK responses.
Source: NPD Genetically Modified Organism (GMOs) Consumer Survey, 2000. -17-
Table 4.  Maximum likelihood estimates from ordered probit model: Public acceptance of
Genetically Modified Organisms.
















*** 12.25  1.9483















*** 14.79  0.1582
*** 10.54  0.1359
*** 10.42
SAFE_1 -0.0687
*** 3.427  0.0052 0.159 -0.1148
*** 4.493
KNOW_1  0.0612
*** 2.625  0.0809
*** 2.375  0.0458 1.420
AWARE_1  0.0312
*** 2.653  0.0321
** 2.005  0.0288
* 1.646
TRUST_1  0.0889
*** 4.309  0.0631




*** 2.159 - - - -
$1  0.9943 20.39 1.012 12.93 0.992 15.77
$2  1.9006 32.09 1.874 20.32 1.939 24.83
$3  3.17 43.48 3.07 28.00 3.289 33.08
$4  4.46 47.66 4.26 31.42 4.680 35.52
Log-L -2409.73 -1042.38 -1356.89
Log-L (!=0) -3410.9 -1498.34 -2049.45
#
2- statistic  2106  817.62 1287.39
Scaled R
2 0.732  0.683 0.738
No. of Obs.  1995  834 1161
*  P < 0.1; 
** P < 0.05; and 
*** P < 0.01.  
1 COUNTRY denotes a binary variable equal to one if the
respondent is from the U.S.  
2 Critical value of chi-square with 10 degrees of freedom is 25.19 at %=0.01.-18-
Table 5. Definitions and descriptive statistics of variables used in the Health Risk Perception model.
Variable Description Mean St. Dev.
Dependent Variable




PROBABILITY What do you think is the likelihood of health hazards from
eating genetically modified foods?
2
3.55(3.56) 1.48(1.46)
SEVERITY If any health problems should occur, how severe do you
think they would be?
3
3.71(3.96) 1.45(1.39)
INFORMATION I feel that there is enough information available for people
to form an opinion about genetically modified foods.
1
2.52(2.60) 1.42(1.45)
OUTRAGE How do you feel about the fact that conventional foods are
currently not labeled differently than genetically modified




    GENDER
    EDUCATION
    
    AGE
1=Male; 0= Otherwise
1 = Grade 2 = Some high 3 = Graduated high 4 = Some
college, 5 = Graduated college, and 6 = Post college
graduate 




1 1= Disagree Completely, 6= Agree Completely. 
2 1 = Extremely low, 2 = Extremely high.  
3 1 = Not at all severe, 6
= Extremely Severe. 
 4 1 = Not bothered, 6 = Extremely bothered
Source: NPD Genetically Modified Organisms Consumer Survey, 2000.-19-
Table 6.  Maximum likelihood estimates from ordered probit models of health risk perception:
Probability, Severity and Demographics









Constant -0.6285 3.466 -1.6919 10.64
Probability  0.5707 17.49  0.7736 25.99
Severity  0.3632 10.96  0.2917 10.53
Age -0.0012 0.518  0.0108 4.379
Education -0.0443 1.969  0.0079 0.358
Gender -0.1299 2.162 -0.2234 3.850
Scaled R
2 0.678 0.732
No. of Obs. 1339 1566
Table 7.  Maximum likelihood estimates from ordered probit models of health risk perception:
Awareness, Trust, Information and Labeling.









Constant  0.7267 4.463  1.055 6.728
AWARENESS -0.0406 3.488 -0.0256 2.089
TRUST -0.1097 4.598 -0.2315 10.39
INFORMATION -0.0463 2.001 -0.0508 2.568
LABEL  0.4462 18.88  0.3695 17.48
Scaled R
2 0.4194 0.4394
No. of Obs. 1281 1617